Acquisition Details - Solaris Energy Infrastructure, Inc. completed the acquisition of Mobile Energy Rental LLC for a total consideration of $136.7 million, which includes $60 million in cash and 16,464,778 units of Solaris LLC[2]. - Solaris incurred $162 million of additional debt to refinance existing debt and fund the cash due at closing of the transaction[3]. - The acquisition method of accounting was used, with assets and liabilities recorded at their fair values as of the acquisition date[3]. - The transaction is subject to closing adjustments that have not yet been finalized, indicating potential variability in the final accounting[8]. - The transaction will increase non-controlling interest by $1.5 million due to the issuance of 16.5 million Solaris LLC units to MER members[30]. Financial Projections - The pro forma combined total revenue for the year ended December 31, 2024, is projected to be $339.033 million, reflecting an increase from historical revenues[11]. - Total operating costs and expenses for the pro forma combined entity are projected to be $295.378 million, resulting in an operating income of $43.655 million[11]. - The transaction is expected to enhance Solaris's service and leasing revenue, with service revenue projected at $264.260 million and leasing revenue at $60.141 million[11]. - Total revenues for the pro forma year ended December 31, 2024 are projected to be $23,721 thousand, with lease income contributing $7,821 thousand and service revenue at $2,103 thousand[20]. - Net income for the pro forma year ended December 31, 2024 is estimated at $12,930 thousand, reflecting a significant increase from historical performance[20]. Earnings and Expenses - The pro forma combined net income attributable to common shareholders is estimated at $6.246 million, with earnings per share of $0.22 on a diluted basis[11]. - Pro forma earnings per share for Class A common stock are projected at $0.22 (basic) and $0.21 (diluted) for the year ended December 31, 2024[32]. - The provision for income taxes is estimated at $5.7 million for the year ended December 31, 2024, based on a historical effective tax rate of 20.2%[29]. - The pro forma adjustment to interest expense for the year ended December 31, 2024 is estimated to be a net reduction of $5,442 thousand, with a variable interest rate assumed at 10.8%[24]. - The company anticipates an additional pro forma depreciation and amortization expense of $8,422 thousand related to the acquisition of identifiable property and equipment[26]. Management Insights - Solaris's management believes the pro forma financial statements reflect necessary adjustments to present fairly the combined financial information[6]. - The pro forma adjustments are preliminary and may change as additional information becomes available, potentially impacting the financial statements materially[8]. - The pro forma adjustments include the elimination of historical interest expenses totaling $12,820 thousand, enhancing the overall financial outlook[24]. - The company expects to depreciate equipment held for lease once delivered, with significant investments in "Construction in Progress" for turbines and other equipment[28].

Acquisition Details - Solaris Energy Infrastructure, Inc. completed the acquisition of Mobile Energy Rental LLC for a total consideration of $136.7 million, which includes $60 million in cash and 16,464,778 units of Solaris LLC and an equal number of shares of Class B Common Stock[2] - Solaris incurred $162 million of additional debt to refinance existing debt and fund the cash due at closing of the transaction[3] - The acquisition method of accounting was used, with assets and liabilities recorded at their fair values as of the acquisition date[3] - The transaction is subject to closing adjustments that have not yet been finalized, indicating potential variability in the final accounting[8] Financial Projections - The pro forma combined total revenue for the year ended December 31, 2024, is projected to be $339.033 million, reflecting an increase from historical revenues[11] - The pro forma operating income is estimated at $43.655 million, with total operating costs and expenses amounting to $295.378 million[11] - Net income attributable to common shareholders is projected to be $6.246 million, with earnings per share of $0.22 on a diluted basis[11] - Total revenues for the pro forma year ended December 31, 2024 are projected to be $23,721 thousand, with lease income contributing $7,821 thousand and service revenue at $2,103 thousand[20] - Net income for the pro forma year ended December 31, 2024 is estimated at $12,930 thousand, reflecting a significant increase from historical figures[20] Revenue Breakdown - The transaction is expected to enhance Solaris's service and leasing revenue, with service revenue projected at $264.260 million and leasing revenue at $60.141 million[11] Pro Forma Adjustments - The pro forma adjustments are preliminary and may change as additional information becomes available, potentially impacting the financial statements materially[8] - Solaris management believes the pro forma financial statements reflect necessary adjustments to present the combined financial information fairly[6] - The pro forma adjustment to interest expense for the year ended December 31, 2024 is estimated to be a net reduction of $5,442 thousand, with a variable interest rate assumed at 10.8%[24] - The company anticipates an additional pro forma depreciation and amortization expense of $8,422 thousand related to the acquisition of identifiable property and equipment[26] - The effective combined U.S. federal and state income tax rate used for pro forma adjustments is 20.2%, leading to a provision for income taxes of $5.7 million[29] - The pro forma adjustment includes the elimination of historical non-leasing depreciation and amortization expenses, resulting in a new depreciation expense of $219 thousand[25] Equipment Depreciation - The company expects to depreciate equipment held for lease once it is delivered and ready for use within the next twelve months[28] Non-Controlling Interests - The transaction resulted in a net loss related to non-controlling interests of $1.5 million due to the issuance of 16.5 million Solaris LLC units[30] Earnings Per Share - Pro forma earnings per share for Class A common stock are projected at $0.22 (basic) and $0.21 (diluted) for the year ended December 31, 2024[32]

Our mandate is getting to breakeven for you, our shareholders. In order to do that, we must realign the business. We are aggressively attacking our cost structure to support this priority with an aim to be EBITDA positive in Q4 2025. Concurrently, we are also focusing on larger revenue, higher margin programs to be more selective in where we focus our limited resources. Exhibit 99.1 Super League Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Update on Strategic Discussions to Accel ...

Financial Performance - Super League reported Q4 2024 revenue of $3.426 million, a decrease from $9.510 million in Q4 2023, and full-year revenue of $16.182 million, down from $25.079 million in 2023[15]. - The company experienced a net loss of $5.127 million in Q4 2024, compared to a net loss of $13.274 million in Q4 2023, and a full-year net loss of $16.474 million, down from $30.330 million in 2023[15]. - Super League's gross profit for Q4 2024 was $999,000, down from $3.725 million in Q4 2023, indicating challenges in maintaining profitability[15]. - The net loss for the fiscal year ended December 31, 2024, was $16,474,000, a significant improvement from a net loss of $30,330,000 in 2023, representing a reduction of approximately 46%[21]. Assets and Liabilities - Total current assets decreased to $5.753 million in 2024 from $16.758 million in 2023, while total liabilities reduced to $11.380 million from $15.338 million[14]. - Super League's cash and cash equivalents decreased to $1.310 million in 2024 from $7.609 million in 2023, reflecting liquidity challenges[14]. - Cash and cash equivalents at the end of the period were $1,310,000, down from $7,609,000 at the beginning of the period, reflecting a net decrease of $6,299,000[21]. Operational Efficiency - The company reported a significant reduction in operating expenses, totaling $5.602 million in Q4 2024 compared to $16.661 million in Q4 2023[15]. - Net cash used in operating activities decreased to $11,581,000 from $15,489,000, indicating improved operational efficiency[21]. - The company experienced a positive change in accounts receivable of $4,521,000, compared to a negative change of $2,113,000 in the previous year[21]. Strategic Initiatives - Super League aims to achieve EBITDA positivity by Q4 2025 through aggressive cost structure realignment and focusing on higher-margin programs[4]. - The company is exploring strategic alternatives to enhance revenue and has identified potential partnerships that could accelerate its path to profitability[7]. - The company appointed Bant Breen to the Board of Directors to leverage his extensive marketing and media experience for revenue growth[6]. Financing Activities - Proceeds from the issuance of preferred stock, net, amounted to $2,393,000, while proceeds from the issuance of common stock were $1,000,000[21]. - Net cash provided by financing activities was $5,446,000, a decrease from $21,441,000 in the prior year, reflecting a shift in financing strategy[21]. - The company incurred a loss on extinguishment of liability related to contingent consideration amounting to $336,000[21]. - The total cash paid in connection with the Melon Acquisition was $150,000, indicating ongoing investment in strategic acquisitions[21]. Shareholder Impact - Super League's weighted-average shares outstanding increased to 13,794,441 in Q4 2024 from 4,264,905 in Q4 2023, impacting per-share loss calculations[19]. - Depreciation and amortization expenses decreased to $2,612,000 from $5,376,000, indicating a reduction in asset-related costs[21]. - The company reported a gain of $311,000 from the sale of Minehut assets, contributing positively to cash flow[21].

Financial Performance - Total Revenues for Q4 2024 increased by 29.3% (or $13.3 million) to $58.6 million compared to $45.3 million in Q4 2023[8] - Operating Income improved from a loss of $7.0 million in Q4 2023 to a positive Operating Income of $1.5 million in Q4 2024[8] - Net Loss decreased from $12.4 million in Q4 2023 to $2.2 million in Q4 2024, driven by improved cinema and real estate revenue[8] - Adjusted EBITDA for Q4 2024 improved by 250.5% to a positive $3.4 million from a negative $2.2 million in Q4 2023[8] - Total revenues for 2024 were $210,527, a decrease of 5% from $222,744 in 2023[28] - Operating loss for 2024 was $14,033, compared to a loss of $12,031 in 2023[28] - Net loss attributable to Reading International, Inc. was $35,301 in 2024, compared to a loss of $30,673 in 2023[28] - Basic and diluted earnings per share for 2024 were both $(1.58), compared to $(1.38) in 2023[28] - Adjusted EBITDA for the year ended December 31, 2024, was $2,113, compared to $7,757 in 2023[32] Revenue Breakdown - Global cinema revenue for the full year 2024 decreased by 6.0% to $195.1 million compared to 2023[13] - Cinema revenues decreased by 6% to $195,130 in 2024 from $207,641 in 2023, while real estate revenues increased slightly by 2%[28] - Global Real Estate Division revenues increased by 1% to $20.0 million in 2024 from $19.9 million in 2023[12] Real Estate and Assets - The occupancy rate of the Australian and New Zealand real estate portfolio was 96%[10] - Cash and cash equivalents as of December 31, 2024, were $12.3 million, with total outstanding bank borrowings of $202.7 million[16] - The company sold its Wellington, New Zealand assets for NZ$38 million on January 31, 2025, and agreed to lease back the cinema component[10] Future Outlook - Anticipated future releases include titles like Disney's Lilo & Stitch and Mission Impossible: The Final Reckoning, which are expected to strengthen performance in 2025[10] EBITDA Insights - EBITDA is used by the company as a measure of financial performance and value, commonly adopted in the cinema exhibition and real estate industries[36] - The company believes EBITDA is valuable for comparing its ability to generate cash against peers in the same industry[36] - Adjusted EBITDA is calculated by excluding certain external items, such as legal expenses related to extraordinary litigation[40] - The company acknowledges that EBITDA does not account for interest, taxes, depreciation, and amortization, which are real costs[39] - A substantial portion of funds depicted by EBITDA may be subject to contractual restrictions and may not be available for discretionary use[38] - The company emphasizes that EBITDA should not be considered in isolation or as a substitute for net income or cash flow data[37] - The exclusion of various components limits the usefulness of EBITDA when assessing financial performance[37] - The company adjusts EBITDA for items considered non-recurring, in accordance with SEC requirements[40] - Analysts and financial commentators typically value enterprises in the cinema exhibition and real estate sectors at various multiples of EBITDA[36] - The company monitors EBITDA to judge its performance against market expectations and creditworthiness[36]

Key Financial Results – Fourth Quarter 2024 compared to Fourth Quarter 2023 The New Zealand dollar average exchange rates weakened against the U.S. dollar by 2.1%, compared to Q4 2023, and the Australian dollar average exchange rates weakened against the U.S. dollar by 0.8% compared to Q4 2023. Despite the weakening both AU and NZ exchange rate against the U.S. dollar, our global revenue improved by 29.3%. Key Financial Results – Full Year 2024 compared to Full Year 2023 Put For more information, contact: G ...

Financial Performance - For the year ended December 31, 2024, the company reported net losses of $53.9 million and used $28.7 million in net cash for operating activities[46]. - The company anticipates continued net losses and cash outflows for the foreseeable future, with no guarantee of achieving profitability[44]. - As of December 31, 2024, the company had cash and cash equivalents of $9.8 million, estimating sufficient liquidity to continue operations through at least December 31, 2025[47]. - The company has no approved drugs for sale and generates no revenues from product sales, indicating a high level of risk in its business model[50]. - The company has not generated any revenue from developed product sales and may face unforeseen expenses and difficulties that could adversely affect its financial condition and prospects[54]. Product Development and Regulatory Challenges - The company is heavily reliant on the success of vebreltinib, its most advanced product candidate, which requires additional clinical development and regulatory approval[50]. - Clinical trials for product candidates are complex and expensive, with a high risk of failure, impacting the timeline for regulatory approval and commercialization[65]. - The company may need to conduct additional clinical trials if initial results are inconclusive, which could increase development costs and delay market entry[70]. - Regulatory acceptance of foreign clinical trial data is uncertain, as demonstrated by the FDA's previous concerns regarding data collected exclusively in China[69]. - The process of developing and obtaining regulatory approval for product candidates is lengthy, complex, and costly, with no guarantee of success[97]. Strategic Partnerships and Collaborations - The company has entered into a collaboration agreement with LaunXP for the development and commercialization of vebreltinib in Asia, excluding mainland China[51]. - Collaboration relationships with several biotechnology companies are in place, but the company has yet to demonstrate its capability to launch and commercialize product candidates independently[55]. - A recent collaboration with LaunXP may face challenges if GLP and GCP compliance is not met, potentially delaying the development of vebreltinib[148]. Market and Competitive Landscape - The company faces substantial competition from larger pharmaceutical and biotechnology companies, which may have greater resources and expertise[109]. - The introduction of generic drugs and alternative cancer treatments could adversely affect market acceptance and sales of the company's product candidates[112]. - The potential market for product candidates may be limited to patients who are ineligible for established therapies or have failed prior treatments, impacting profitability[102]. Operational and Management Risks - The company has implemented significant expense reductions and narrowed its development focus to prioritize vebreltinib and uproleselan[47]. - The company has recently reduced its workforce to 13 full-time employees as part of cost-cutting measures, which may impact operational management[119]. - Retaining key executives and qualified personnel is critical for the company's success, and any unanticipated departures could adversely affect operations[114]. - The company may face challenges in managing operations effectively due to limited financial resources and changes in employee numbers[120]. Legal and Compliance Risks - The company is currently defending a legal claim in the Grand Court of the Cayman Islands, which may result in substantial costs and resource diversion[121]. - The company faces inherent risks of product liability exposure during human clinical trials, which could lead to civil and administrative liabilities[122]. - Non-compliance with anti-bribery laws could harm the company's reputation and result in significant penalties[203]. Intellectual Property Risks - The company faces risks related to intellectual property rights, including challenges to patent protection that could impact commercialization efforts[226]. - Competitors may develop similar technologies in a non-infringing manner, limiting the effectiveness of the company's patent portfolio[232]. - Changes in patent laws could diminish the value and scope of the company's patents, particularly under the "first-to-file" system adopted in the US and China[233]. Currency and International Operations - The company incurs expenses in currencies other than the U.S. dollar, exposing it to foreign currency exchange risk, particularly with the Renminbi and Australian dollar[133]. - International markets are crucial for growth, but failure to secure licenses or successful collaborations could adversely affect revenue potential[134]. - The PRC government imposes controls on currency conversion, which may delay cash transfers from PRC subsidiaries to the company[204]. Regulatory Environment in China - The company faces risks related to evolving laws and regulations in China, which could materially affect operations and capital raising efforts[207]. - Compliance with evolving cybersecurity and data protection laws in the PRC is critical, as non-compliance could adversely affect business operations[212]. - The implementation of strict labor laws in China may increase operating expenses and limit employment practices[224].

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended June 30, 2024 OR ☐ Transition report pursuant to Section 13 of 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number: 000-23329 Charles & Colvard, Ltd. (Exact name of registrant as specified in its charter) North Carolina 56-1928817 (State or other jurisdict ...

FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 3, 2025 BLUE OWL CAPITAL CORPORATION (Exact name of Registrant as Specified in Its Charter) Maryland 814-01190 47-5402460 (State or Other Jurisdiction of Incorporation) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communicatio ...

Financial Performance - Net sales for the thirteen weeks ended February 23, 2025, were $2,841.0 million, a decrease of 6.3% compared to $3,032.9 million for the same period in 2024[8]. - Net income for the thirty-nine weeks ended February 23, 2025, was $896.5 million, down 2.9% from $914.9 million for the same period in 2024[8]. - Earnings per share (EPS) for the thirteen weeks ended February 23, 2025, were $0.30, a decline of 53.1% compared to $0.64 for the same period in 2024[8]. - Comprehensive income attributable to Conagra Brands, Inc. for the thirty-nine weeks ended February 23, 2025, was $889.0 million, compared to $915.1 million for the same period in 2024[11]. - Net income for the thirty-nine weeks ended February 23, 2025, was $896.5 million, down from $914.9 million for the same period in the previous year, representing a decrease of about 2.6%[16]. - Net income attributable to Conagra Brands, Inc. for the thirty-nine weeks ended February 23, 2025, was $466.8 million, compared to $284.5 million for the same period in the previous year, representing a year-over-year increase of 64%[87]. - The company reported a net income of $145.1 million for the thirteen weeks ended February 23, 2025, compared to $308.8 million in the same period last year, reflecting a decrease of 53.0%[106]. - Diluted earnings per share for Q3 fiscal 2025 was $0.30, down from $0.64 in Q3 fiscal 2024, reflecting lower net income[116]. Expenses and Costs - Selling, general and administrative expenses increased to $443.7 million for the thirteen weeks ended February 23, 2025, up 14.5% from $387.4 million in the same period in 2024[8]. - The cost of goods sold for the thirty-nine weeks ended February 23, 2025, was $6,534.7 million, a decrease of 1.2% from $6,616.5 million in the same period in 2024[8]. - Interest expense, net, for the thirty-nine weeks ended February 23, 2025, was $314.9 million, down from $325.8 million for the same period in 2024[8]. - The company recognized an impairment charge of $27.2 million in the Refrigerated & Frozen segment during Q3 fiscal 2025[97]. - The company incurred asset impairment charges of $121.3 million during the period, compared to $50.9 million in the previous year[16]. Assets and Liabilities - Total current assets decreased from $3,149.5 million to $2,965.6 million, a decline of approximately 5.8%[13]. - Total liabilities decreased from $12,351.0 million to $11,965.4 million, a reduction of about 3.1%[13]. - Cash and cash equivalents at the end of the period decreased to $49.4 million from $77.7 million, a decline of approximately 36.4%[16]. - Current liabilities increased to $4,303.7 million as of February 23, 2025, compared to $3,241.8 million as of May 26, 2024, an increase of 33.0%[13]. - Goodwill increased from $10,325.9 million as of May 26, 2024, to $10,499.8 million as of February 23, 2025, reflecting an acquisition of $176.2 million and a currency translation adjustment of $(2.3) million[51]. Acquisitions and Divestitures - The company acquired Sweetwood Smoke & Co. for $179.4 million, with $129.9 million classified as goodwill[24]. - The company completed the sale of its 51.8% ownership stake in Agro Tech Foods Limited for net proceeds of $76.8 million, recognizing a loss of $2.3 million on the sale[27]. - The company recognized a loss on divestitures of $27.2 million for the thirteen weeks ended February 23, 2025, compared to no loss in the same period in 2024[8]. Restructuring and Plans - The Conagra Restructuring Plan has incurred cumulative charges of $310.2 million, with $90.7 million recognized in the first three quarters of fiscal 2025[34]. - The company has approved a total of $345.9 million for the Conagra Restructuring Plan, with $90.1 million in cash charges and $255.8 million in non-cash charges recognized[34]. - The company initiated plans to sell businesses within its Grocery & Snacks, Refrigerated & Frozen, and International segments, recognizing an impairment charge of $27.2 million in the third quarter of fiscal 2025[30]. Cash Flow and Financing - The company reported net cash flows from operating activities of $1,346.2 million, compared to $1,531.3 million in the prior year, a decrease of approximately 12.1%[16]. - Cash used in investing activities amounted to $457.2 million in the first three quarters of fiscal 2025, compared to $295.6 million in the same period of fiscal 2024[165]. - Cash used in financing activities was $914.3 million in the first three quarters of fiscal 2025, down from $1.25 billion in fiscal 2024, reflecting long-term debt repayments of $274.8 million and cash dividends paid of $502.2 million[166]. - The company repaid $1.0 billion of its 4.30% senior notes on May 1, 2024, funded by an unsecured term loan and commercial paper[37]. Market and Economic Conditions - The company anticipates ongoing challenges related to inflation, supply chain issues, and changing consumer preferences impacting future performance[111]. - The company anticipates continued economic pressures on consumers, including high inflation and potential tariff increases, which may affect volumes[118].